Home/SEC 13D/G/RLMDSEC 13D/G$RLMD SEC Filing Update (09-JUN-2026) | ThinkSabio - Stocks Simplified$RLMD$6.30▲ 44.16% YTDHealthcareJun 10, 2026 · ThinkSabio BlogSEC Filing Update: #RLMD : $6.30 Sector: Healthcare | YTD: 🔼+ 44.16% The SEC disclosed Today (09-JUN-2026) that VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. has Newly bought 6,508,433 #RLMD shares Ownership: 6.2% * Estimated Investment Value: $42.63M https://www.thinksabio.com/reports/isr/RLMD Institutional ownership in #RLMD has been steadily rising over the past 4 quarters in Shares: Q2 2025: 5.30M Q3 2025: 7.74M Q4 2025: 50.92M Q1 2026: 83.66M The quarterly average prices of #RLMD: Q1 2025: $0.30 Q2 2025: $0.51 Q3 2025: $0.96 Q4 2025: $3.33 Q1 2026: $4.72 Share this post🔗Copy LinkMore filings for $RLMDRLMD - Relmada Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$RLMD SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026$RLMD SEC Filing Update (22-JUN-2026) | ThinkSabio - Stocks SimplifiedJun 22, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G